Diagnostic accuracy of the Fibrosis-4 (FIB-4) index for advanced liver fibrosis in Qatari patients with MASLD: Comparison with liver biopsy and FibroScan

Bibliographic Information
Authors: Derbala M.; Obeidat I.M.; Abualsuod R.; Draidi M.; Selim N.; Maatoug J.; Elkalamawi A.
Journal: Qatar Medical Journal
Publisher: HBKU Press
Publication Date: 2026
Volume / Issue: Volume 2026 / Issue 2
Article No.: 32
ISSN: 2538253
DOI: 10.5339/qmj.2026.32
Scopus: View on Scopus
Document Type: Article
Access: All Open Access; Gold Open Access; Green Open Access
Authors and Affiliations
Derbala M., Gastroenterology and Hepatology, Hamad Medical Corporation, Doha, Qatar, Theodore Bilharz Research Institute, Warraq Al Hadar, Egypt, Weill Cornell Medical College, Ar-Rayyan, Qatar; Obeidat I.M., Gastroenterology and Hepatology, Hamad Medical Corporation, Doha, Qatar; Abualsuod R., Internal Medicine Department, Hamad Medical Corporation, Doha, Qatar; Draidi M., Internal Medicine Department, Hamad Medical Corporation, Doha, Qatar; Selim N., Community and Preventive Medicine Department, Primary Health Care Corporation, Doha, Qatar; Maatoug J., Community and Preventive Medicine Department, Primary Health Care Corporation, Doha, Qatar, Faculty of Medicine of Sousse, Sousse University, Sousse, Tunisia; Elkalamawi A., Epidemiology-Medicine, Lincoln University, Kota Bharu, Malaysia
Abstract
Background: Metabolically-dysfunction-associated steatotic liver disease (MASLD) is highly prevalent in populations with metabolic risk factors, and the liver fibrosis stage is the main determinant of long-term outcomes. The Fibrosis-4 (FIB-4) index is widely recommended as a first-line noninvasive test for fibrosis risk stratification; however, its diagnostic performance may vary across populations. Objective: To evaluate the diagnostic performance of the FIB-4 index for detecting advanced liver fibrosis in Qatari residents with MASLD, using liver biopsy as the primary reference standard and FibroScan as a secondary comparator. Methodology: This retrospective, cross-sectional diagnostic accuracy study included adults with MASLD evaluated at Hamad Medical Corporation in Qatar between January 2023 and December 2024. FIB-4 was calculated from routine laboratory parameters, and fibrosis was staged using the METAVIR (Meta-Analysis of Histological Data in Viral Hepatitis) scoring system. It is a histological scoring system used to grade necroinflammatory activity (A0–A3) and stage liver fibrosis (F0–F4). Advanced fibrosis was defined as METAVIR stage ≥F3. Diagnostic performance metrics and the area under the receiver operating characteristic curve (AUROC) were calculated at established cut-offs. Results: A total of 117 patients were included; 74 patients (63.2%) underwent liver biopsy, and 91 patients (77.7%) underwent FibroScan assessment. Advanced fibrosis was present in 21 patients (17.9%) on biopsy. At a FIB-4 cut-off of 1.3, sensitivity and specificity for detecting advanced fibrosis were 66.7% and 67.9%, respectively, compared with liver biopsy, with an overall accuracy of 67.6% and a negative predictive value of 83.7%. The AUROC for FIB-4 was 0.76. Conclusion: FIB-4 can be used as a first-line, accountable screening tool, followed by another confirmatory tool in high-risk patients. © 2026 Derbala, Obeidat, Abualsuod, Draidi, Selim, Maatoug, et al., licensee HBKU Press.
Keywords
accuracy; FIB-4; FibroScan; Fibrosis-4 index; liver biopsy; MASLD; adult; Article; controlled study; cross-sectional study; diabetes mellitus; diagnostic accuracy; dyslipidemia; human; human cell; human tissue; hypertension; liver fibrosis; major clinical study; medical record review; metabolic fatty liver; necroinflammation; obese patient; obesity; performance indicator; predictive value; Qatar; Qatari; receiver operating characteristic; retrospective study; risk factor; sensitivity and specificity; transient elastography
Citation Information
Scopus Citations: 0
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
